 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.3.2.13
- Protein-glutamine gamma-glutamyltransferase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Protein glutamine + alkylamine = protein N5-alkylglutamine + NH3
|
 |
 |
 |
 |
 |
Protein glutamine
|
+
|
alkylamine
|
=
|
protein N(5)-alkylglutamine
|
+
|
NH(3)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Cofactor:
|
 |
Calcium
|
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
3 terms
|
 |
|
Biological process
|
wound healing
|
5 terms
|
 |
|
Biochemical function
|
transferase activity
|
4 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Thromb Res
78:389-397
(1995)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural evidence that the activation peptide is not released upon thrombin cleavage of factor XIII.
|
|
V.C.Yee,
L.C.Pedersen,
P.D.Bishop,
R.E.Stenkamp,
D.C.Teller.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The three-dimensional structure of the recombinant human factor XIII a2 dimer
after cleavage by thrombin has been determined by X-ray crystallography. Factor
XIII zymogen was treated with bovine alpha-thrombin in the presence of 3 mM
CaCl2, and the cleaved protein was crystallized from Tris buffered at pH 6.5
using ethanol as the precipitating agent. Refinement of the molecular model of
thrombin-cleaved factor XIII against diffraction data from 10.0 to 2.5 A
resolution has been carried out to give a crystallographic R factor of 18.2%.
The structure of thrombin-cleaved factor XIII is remarkably similar to that of
the zymogen: there are no large conformational changes in the protein and the 37
residue amino terminus activation peptide remains associated with the rest of
the molecule. This work shows that the activation peptide, upon thrombin
cleavage, has the same conformation and occupies the same position with respect
to the rest of the molecule as it does in the zymogen structure.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
I.Komáromi,
Z.Bagoly,
and
L.Muszbek
(2011).
Factor XIII: novel structural and functional aspects.
|
| |
J Thromb Haemost, 9,
9.
|
 |
|
|
|
|
 |
B.A.Wilson,
and
M.Ho
(2010).
Recent insights into Pasteurella multocida toxin and other G-protein-modulating bacterial toxins.
|
| |
Future Microbiol, 5,
1185-1201.
|
 |
|
|
|
|
 |
E.Ortner,
V.Schroeder,
R.Walser,
O.Zerbe,
and
H.P.Kohler
(2010).
Sensitive and selective detection of free FXIII activation peptide: a potential marker of acute thrombotic events.
|
| |
Blood, 115,
5089-5096.
|
 |
|
|
|
|
 |
M.A.Jadhav,
G.Isetti,
T.A.Trumbo,
and
M.C.Maurer
(2010).
Effects of introducing fibrinogen Aalpha character into the factor XIII activation peptide segment.
|
| |
Biochemistry, 49,
2918-2924.
|
 |
|
|
|
|
 |
N.Louhichi,
M.Medhaffar,
I.Hadjsalem,
E.Mkaouar-Rebai,
N.Fendri-Kriaa,
H.Kanoun,
F.Yaïch,
T.Souissi,
M.Elloumi,
and
F.Fakhfakh
(2010).
Congenital factor XIII deficiency caused by two mutations in eight Tunisian families: molecular confirmation of a founder effect.
|
| |
Ann Hematol, 89,
499-504.
|
 |
|
|
|
|
 |
V.Ivaskevicius,
A.Biswas,
C.Bevans,
V.Schroeder,
H.P.Kohler,
H.Rott,
S.Halimeh,
P.E.Petrides,
H.Lenk,
M.Krause,
B.Miterski,
U.Harbrecht,
and
J.Oldenburg
(2010).
Identification of eight novel coagulation factor XIII subunit A mutations: implied consequences for structure and function.
|
| |
Haematologica, 95,
956-962.
|
 |
|
|
|
|
 |
U.Tagami,
N.Shimba,
M.Nakamura,
K.Yokoyama,
E.Suzuki,
and
T.Hirokawa
(2009).
Substrate specificity of microbial transglutaminase as revealed by three-dimensional docking simulation and mutagenesis.
|
| |
Protein Eng Des Sel, 22,
747-752.
|
 |
|
|
|
|
 |
V.Ivaskevicius,
J.Windyga,
B.Baran,
V.Schroeder,
J.Junen,
K.Bykowska,
E.Seifried,
H.P.Kohler,
and
J.Oldenburg
(2007).
Phenotype-genotype correlation in eight Polish patients with inherited Factor XIII deficiency: identification of three novel mutations.
|
| |
Haemophilia, 13,
649-657.
|
 |
|
|
|
|
 |
W.Onland,
A.N.Böing,
A.B.Meijer,
M.C.Schaap,
R.Nieuwland,
K.Haasnoot,
A.Sturk,
and
M.Peters
(2005).
Congenital deficiency of factor XIII caused by two missense mutations in a Dutch family.
|
| |
Haemophilia, 11,
539-547.
|
 |
|
|
|
|
 |
A.Vysokovsky,
R.Saxena,
M.Landau,
A.Zivelin,
R.Eskaraev,
N.Rosenberg,
U.Seligsohn,
and
A.Inbal
(2004).
Seven novel mutations in the factor XIII A-subunit gene causing hereditary factor XIII deficiency in 10 unrelated families.
|
| |
J Thromb Haemost, 2,
1790-1797.
|
 |
|
|
|
|
 |
T.Kashiwagi,
K.Yokoyama,
K.Ishikawa,
K.Ono,
D.Ejima,
H.Matsui,
and
E.Suzuki
(2002).
Crystal structure of microbial transglutaminase from Streptoverticillium mobaraense.
|
| |
J Biol Chem, 277,
44252-44260.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.S.Weiss,
and
R.Hilgenfeld
(1999).
Dehydration leads to a phase transition in monoclinic factor XIII crystals.
|
| |
Acta Crystallogr D Biol Crystallogr, 55,
1858-1862.
|
 |
|
|
|
|
 |
M.S.Weiss,
and
R.Hilgenfeld
(1999).
A method to detect nonproline cis peptide bonds in proteins.
|
| |
Biopolymers, 50,
536-544.
|
 |
|
|
|
|
 |
T.S.Lai,
T.F.Slaughter,
K.A.Peoples,
and
C.S.Greenberg
(1999).
Site-directed mutagenesis of the calcium-binding site of blood coagulation factor XIIIa.
|
| |
J Biol Chem, 274,
24953-24958.
|
 |
|
|
|
|
 |
E.Candi,
G.Melino,
A.Lahm,
R.Ceci,
A.Rossi,
I.G.Kim,
B.Ciani,
and
P.M.Steinert
(1998).
Transglutaminase 1 mutations in lamellar ichthyosis. Loss of activity due to failure of activation by proteolytic processing.
|
| |
J Biol Chem, 273,
13693-13702.
|
 |
|
|
|
|
 |
O.V.Mitkevich,
J.R.Shainoff,
P.M.DiBello,
V.C.Yee,
D.C.Teller,
G.B.Smejkal,
P.D.Bishop,
I.S.Kolotushkina,
K.Fickenscher,
and
G.P.Samokhin
(1998).
Coagulation factor XIIIa undergoes a conformational change evoked by glutamine substrate. Studies on kinetics of inhibition and binding of XIIIA by a cross-reacting antifibrinogen antibody.
|
| |
J Biol Chem, 273,
14387-14391.
|
 |
|
|
|
|
 |
V.C.Yee,
K.P.Pratt,
H.C.Côté,
I.L.Trong,
D.W.Chung,
E.W.Davie,
R.E.Stenkamp,
and
D.C.Teller
(1997).
Crystal structure of a 30 kDa C-terminal fragment from the gamma chain of human fibrinogen.
|
| |
Structure, 5,
125-138.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|